CytoDyn Inc. Adjustments to Additional Paid in Capital, Warrant Issued
CytoDyn Inc. (CYDY) reported Adjustments to Additional Paid in Capital, Warrant Issued of $359.00 thousand for the 12-month period ending 2024-05-31, per its S-1 filed 2026-04-22.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2026-04-22
- CytoDyn Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2024-02-29 was $179.00K.
- CytoDyn Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2023-11-30 was $10.00K.
- CytoDyn Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2023-08-31 was $170.00K, a 95.95% decline year-over-year.
- CytoDyn Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2023-05-31 was -$2.09M.
- CytoDyn Inc. adjustments to additional paid in capital, warrant issued for fiscal 2023 was $114.00K.
- CytoDyn Inc. adjustments to additional paid in capital, warrant issued for fiscal 2018 was $826.25K, a 1040.70% increase from fiscal 2017.
- CytoDyn Inc. adjustments to additional paid in capital, warrant issued for fiscal 2017 was $72.43K.
- CytoDyn Inc. adjustments to additional paid in capital, warrant issued for fiscal 2015 was $970.37K, a 402.36% increase from fiscal 2014.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|---|
| 2024-05-31 | $359.00K S-1 · filed 2026-04-22 | |||
| 2024-02-29 | $179.00K 10-Q · filed 2025-04-14 | $189.00K derived: sum of 2 quarters · filed 2025-04-14 | $359.00K derived: sum of 3 quarters · filed 2025-04-14 | -$1.73M derived: sum of 4 quarters · filed 2025-04-14 |
| 2023-11-30 | $10.00K 10-Q · filed 2025-04-14 | $180.00K derived: sum of 2 quarters · filed 2025-04-14 | -$1.91M derived: sum of 3 quarters · filed 2025-04-14 | -$3.91M derived: sum of 4 quarters · filed 2025-04-14 |
| 2023-08-31 | $170.00K 10-Q · filed 2025-04-14 | -$1.92M derived: sum of 2 quarters · filed 2025-04-14 | -$3.92M derived: sum of 3 quarters · filed 2025-04-14 | -$3.92M derived: sum of 4 quarters · filed 2025-04-14 |
| 2023-05-31 | -$2.09M derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-15 | -$4.09M derived: sum of 2 quarters · filed 2024-08-15 | -$4.09M derived: sum of 3 quarters · filed 2024-08-15 | $114.00K 10-K · filed 2024-08-15 |
| 2023-02-28 | -$2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-04-10 | -$2.00M derived: sum of 2 quarters · filed 2023-04-10 | $2.20M 10-Q · filed 2023-04-10 | |
| 2022-11-30 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2023-01-09 | $4.20M 10-Q · filed 2023-01-09 | ||
| 2022-08-31 | $4.20M 10-Q/A · filed 2022-10-13 | |||
| 2018-05-31 | $826.25K 10-K · filed 2020-08-14 | |||
| 2017-08-31 | $826.25K 10-Q · filed 2019-01-09 | |||
| 2017-05-31 | $72.43K 10-K · filed 2019-08-14 | |||
| 2015-05-31 | $970.37K 10-K · filed 2016-07-19 | |||
| 2014-05-31 | $193.16K 10-K · filed 2015-07-10 | |||
| 2012-05-31 | $540.01K 10-K · filed 2013-08-29 |